QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS

We evaluated the quality of life (QOL) in 268 patients with diabetes mellitus (NIDDM, 250 cases; IDDM, 10 cases; and other type of diabetes, 8 cases) to determine which aspects were adversely affected by the disease. Information concerning life satisfaction, social activities, ability to work, sexual problems and physical symptoms was obtained from a 30-item questionnaire. Clinical characteristics including duration of diabetes, glycemic control, current treatment, obesity, hypertension, hyperlipidemia, macro- and microvascular complications were obtained from medical records. Diminished QOL was most pronounced in patients who had had a long duration of disease, required insulin therapy, and whose health was disturbed by cerebrovascular disease, end-stage renal disease, mono- and autonomic neuropathy. A significant difference in the subdimensional QOL score was noted in life satisfaction, social activities, ability to work, sexual problems and physical symptoms under these circumstances

Halogen-free water-immiscible ionic liquids based on tetraoctylammonium cation and dodecylsulfate and dodecylbenzenesulfonate anions, and their application as chelate extraction solvent

The tetraoctylammonium cation forms water-immiscible room temperature ionic liquids with dodecylsulfate and dodecylbenzenesulfonate anions. The ionic liquids are halogen-free and can be considered environmentally friendly solvents. At 25°C, the solubilities of water in tetraoctylammonium dodecylsulfate and tetraoctylammonium dodecylbenzenesulfonate were 2.8 and 4.0%, respectively, and the densities were 0.92 and 0.93 g cm 3. The ionic liquids formed stable interfaces with water at 25°C. The possible use of tetraoctylammonium dodecylsulfate as chelate extraction solvent was evaluated by using 4,4,4-trifluoro-1-(2-thienyl)-1,3-butanedione as extractant. Tetraoctylammonium dodecylsulfate showed high extraction performance for divalent transition metal cations. 2006 © The Japan Society for Analytical Chemistry

Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF

BACKGROUND: Many patients with atrial fibrillation have concomitant coronary artery disease with or without acute coronary syndromes and are in need of additional antithrombotic therapy. There are few data on the long-term clinical outcome of atrial fibrillation patients with a history of acute coronary syndrome. This is a 2-year study of atrial fibrillation patients with or without a history of acute coronary syndromes

Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation A Report From the GARFIELD-AF Registry

IMPORTANCE Congestive heart failure (CHF) is commonly associated with nonvalvular atrial fibrillation (AF), and their combination may affect treatment strategies and outcomes